In relation to the protection of intellectual property, not only clarified Luzzatto Patent Laws in

Space and Astronomy Astrophysics Astronomy Solar System Space Missions man in space Environment and Energy Environmental Science Earth Sciences - Earth Environmental bolton manitoba spa Issues bolton manitoba spa Energy Transport computing technology science bolton manitoba spa and computing and robotics Nano - tech military technology futurism Biology and Medicine Evolution and the Nature Medicine Genetics Brain Society and History and Society bolton manitoba spa History skeptic science fiction scientists science research and development in Israel Israel Israel Israel's biotech space and defense industries Education Academy facebook twitter youtube rss
Israel: As I said - I did not dwell link and I do not ...
"More and more pharmaceutical and biotechnology companies today prefer to make the process of research and development in pharmaceuticals using outsourcing - foreign," said Dr. Kfir Luzzatto, co - director Luzzatto Group, which specializes in intellectual property Ssbthum. Dr. Luzzatto said this at the "Biomed bolton manitoba spa in 2009. "
According to Dr. Luzzatto, outsourcing - Away helps pharmaceutical bolton manitoba spa companies store more potential bolton manitoba spa drugs in the pipeline, accelerate the drug approval process and streamline it and at the same time control the huge development costs. bolton manitoba spa "This is one of the main ways to control spending now massive development of new drugs. It also allows companies to focus and shift the R & D resources on their core activities, "states bolton manitoba spa Dr. Luzzatto says that this led to the closure of some basic research units in many pharmaceutical corporations in the world. Currently, most pharmaceutical companies have research limits and can not expand the their research units, which requires hiring additional professional personnel, laboratories and sophisticated equipment and hence the growing need for outsourced - foreign.
Dr. Kfir Luzzatto said that outsourcing drug development has become a dominant trend in the last five years and in this market segment from the U.S. alone is currently estimated at $ 12 billion. In all the proposed processes to outsource a share of 20% is engaged in the identification and testing of potential drugs.
He said that large pharmaceutical companies and large biotechnology projects will compete for the acquisition of projects and companies bolton manitoba spa with attractive development pipeline. Even companies Agro - Technology will increase, and involves the acquisition of new developments bolton manitoba spa in biotechnology bolton manitoba spa because of the global food crisis. So companies engaged in developing bio - diesel and plant-based fuels are similar trend as companies in the green energy and green solutions.
Dr. Luzzatto also said that according to various estimates the global pharma bolton manitoba spa market - with sales of 773 billion bolton manitoba spa dollars (in 2008) - will shrink by 2.5% -3.5% in 2009. Share of the U.S. market will decline at a rate of 1% - 2% due to the entry of cheaper generic drugs. He added that emerging markets around the world rely more and more on generic drugs and growth in these markets is that slows the process of contraction in the market.
One of the key insights bolton manitoba spa picking Dr. Luzzatto new market is emerging biotechnological developments that companies have adopted and expanded the range of their products are in a better position than companies that were based only on chemical development. Biotechnological products are more sophisticated, bolton manitoba spa more difficult and more expensive to copy development. Yet today 22 biotechnology drugs market turnover of a billion dollars or more each. This is also one reason why large corporations - are turning to national Israel in search of biotechnological developments, due to the high level of R & D and the number of start-ups (start - up) big field.
In relation to the protection of intellectual property, not only clarified Luzzatto Patent Laws in itself or lack disturbing the big investors, bolton manitoba spa but sometimes too aggressive defense. According to him, many entrepreneurs bolton manitoba spa and inventors patent application try to cover most of the possible future applications bolton manitoba spa drug or a particular product, based on current bolton manitoba spa projections, and without the possibility to support the process. Such wide coverage on the basis of forecasts as broad of no use and may even undermine the important key applications of the drug or product in the future. Investor's human will ensure his initial commercial bolton manitoba spa potential future bolton manitoba spa range, combined with a lack of understanding of the schedule bolton manitoba spa required in product development in the life sciences, may turn out to be ineffective and even sabotage the completion of drug development and the achievement of investors.
Search Studies BA | MA | SAT Courses | Practical Studies Classes | Diploma
Non-robotic cars - driving on the roads
Hayadan 2013 All rights reserved